Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diet is a major contributor to metabolic disease risk, but there is controversy as to whether increased incidences of diseases such as non-alcoholic fatty liver disease arise from consumption of saturated fats or free sugars. Here, we investigate whether a sub-set of triacylglycerols (TAGs) were associated with hepatic steatosis and whether they arise from de novo lipogenesis (DNL) from the consumption of carbohydrates. RESULTS: We conduct direct infusion mass spectrometry of lipids in plasma to study the association between specific TAGs and hepatic steatosis assessed by ultrasound and fatty liver index in volunteers from the UK-based Fenland Study and evaluate clustering of TAGs in the National Survey of Health and Development UK cohort. We find that TAGs containing saturated and monounsaturated fatty acids with 16-18 carbons are specifically associated with hepatic steatosis. These TAGs are additionally associated with higher consumption of carbohydrate and saturated fat, hepatic steatosis, and variations in the gene for protein phosphatase 1, regulatory subunit 3b (PPP1R3B), which in part regulates glycogen synthesis. DNL is measured in hyperphagic ob/ob mice, mice on a western diet (high in fat and free sugar) and in healthy humans using stable isotope techniques following high carbohydrate meals, demonstrating the rate of DNL correlates with increased synthesis of this cluster of TAGs. Furthermore, these TAGs are increased in plasma from patients with biopsy-confirmed steatosis. CONCLUSION: A subset of TAGs is associated with hepatic steatosis, even when correcting for common confounding factors. We suggest that hepatic steatosis risk in western populations is in part driven by increased DNL following carbohydrate rich meals in addition to the consumption of saturated fat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, specific TAGs containing palmitate or stearate, i.e. TAG 48:0, 50:0, 48:1 and 50:1, have been associated with the severity of MASLD and with an increased risk of developing T2D.105,106”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [105]
Experimental — accuracy not yet measuredIn the citing paper
“In MASLD, a significant increase in TAGs with lower carbon numbers and double bonds,94,102,105 DAGs,99,102,107 and PE94,[108], [109], [110], [111] has been reported.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“Obesity is responsible for suppression of insulin signalling by hyperactivation of c-jun N-terminal kinase (JNK) through increased ER stress [43, 44].”
BackgroundMetabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · cited 1×
“There has been much interest in the field of metabolomics in the generation of predictive markers of T2DM and its associated metabolic diseases [33, 34].”
BackgroundBedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042 · cited 4×
“Analyses were compared with FLI, based on BMI, waist circumference, total TAGs and plasma levels of GGT [21].”
BackgroundInfluentialPredicting basal metabolic rate, new standards and review of previous work.
Wn, S. (1985) · PubMed · Cited by 2,958
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 1×
“However, TAGs are synthesised via DAGs and these lipids have been shown to interfere with insulin signalling by activating protein kinase CƐ (PKCƐ) which leads to reduced insulin-stimulated insulin receptor substrate 2 (IRS-2) tyrosine phosphorylation [40, 41].”
BackgroundLipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189 · cited 10×
“Across these studies, the TAG species have in common relative enrichments for palmitate, stearate and oleate fatty acids, and studies using gas chromatography (GC)-MS have also reported associations between these FAs from total lipid extracts and increased risk of developing T2DM [15].”
BackgroundInfluentialLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Research works printed but not linked: 2
- Frayn KN. Metabolic reguation: a human perspective. 2nd ed. Oxford: Blackwell Publishing; 2003.
- James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning with applications in R. Springer-Verlag New York: Springer Texts in Statistics; 2015.
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
SpaceM reveals metabolic states of single cells
Rappez, L., Stadler, M., Triana, S., Gathungu, R. M., Ovchinnikova, K., Phapale, P., Heikenwalder, M., & Alexandrov, T. (2021) · Nature Methods · doi:10.1038/s41592-021-01198-0 · Cited by 390
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Self-citationHendriks, D., Brouwers, J. F., Hamer, K., Geurts, M. H., Luciana, L., Massalini, S., López-Iglesias, C., Peters, P. J., Rodríguez-Colman, M. J., Chuva de Sousa Lopes, S., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01680-4 · Cited by 249
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
Mato, J. M., Alonso, C., Noureddin, M., & Lu, S. C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3009 · Cited by 199
Metadata
- Authors
- Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., Vidal-Puig, A., Kuh, D., Hardy, R., Allison, M., Forouhi, N., Murray, A. J., Wareham, N., Vacca, M., Koulman, A., & Griffin, J. L.
- Affiliations
- MRC Elsie Widdowson Laboratory (GB)
- University of Leeds (GB)
- University of Cambridge (GB)
- MRC Unit for Lifelong Health and Ageing (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Griffin, Julian L.
- ORCID
- Venue
- Genome Biology
- Published
- 2018-06-20
- Volume
- 19
- Issue
- 1
- Pages
- 79-79
- ISSN
- 1465-6906 (ISSN-L)
- 1474-760X
- PMC
- PMC6009819
- OpenAlex
- W2809459680
- Cited by
- 114
- References
- 53
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 25 · 2021: 27 · 2020: 11 · 2019: 8 · 2018: 1
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Genome biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by-nc-nd)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Funders
- Medical Research Council (MC UP A90 1006, MC PC 13030, MC UU12015/1, MC UU 12015/5)
- Evelyn Trust (NA)
- National Institutes of Health (1R01ES022186-01)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hepatic steatosis, non-alcoholic fatty liver disease, de novo lipogenesis, triglycerides, saturated fatty acids, monounsaturated fatty acids, carbohydrate intake, saturated fat, PPP1R3B, glycogen synthesis, Western diet, free sugars, plasma lipidomics, direct infusion mass spectrometry, ob/ob mice, stable isotope tracers
- MeSH terms
- Animals, Carbohydrates, Diet, Fatty Liver, Female, Humans, Lipids, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Middle Aged, Risk, Triglycerides, Lipogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption. https://app.cochat.ai/papers/10.1186/s13059-018-1439-8
- The paper
- Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., Vidal-Puig, A., Kuh, D., Hardy, R., Allison, M., Forouhi, N., Murray, A. J., Wareham, N., Vacca, M., Koulman, A., & Griffin, J. L. (2018). Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption. Genome Biology. https://doi.org/10.1186/s13059-018-1439-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.